Andrx Pharmaceuticals

Andrx Pharmaceuticals is applying its proprietary drug delivery technologies and formulation skills to the development of generic versions of difficult to replicate, controlled-release brand name pharmaceuticals, for which marketing exclusivity or patent rights have expired or are near expiration. Andrx Pharmaceuticals' pipeline includes more than 20 abbreviated new drug application products (ANDAs) in various stages of development. The brand versions of these products had reported sales in 1998 exceeding $5 billion.

Activity:

- Research & Development

Product / Technology type(s) covered:

- Drug delivery
- Generics
- Pharmaceuticals / Therapeutics

Therapeutic targets:

Markets Covered

a. HeadQuarter:

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: